Search

everythinglearnresearchcommunity

for

Search:↓

The painting of an 18th-century Sicilian baroness shows she had hair loss, possibly due to ovarian issues, insulin resistance, or a specific type of tumor.

The document's conclusion cannot be provided as the content is not available for parsing.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Ovarian stromal tumors are a rare cause of women developing male characteristics after menopause.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.

A 77-year-old woman with hair loss had high testosterone and 17OH-progesterone levels, but no significant findings on imaging.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

The case highlights the complexity of diagnosing high testosterone in older women and the need for thorough testing.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Bilateral ovarian hyperthecosis is a rare but treatable cause of increased facial hair in postmenopausal women.

Hair loss in postmenopausal woman caused by ovarian issue.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Doctors should check for serious tumor causes of high androgen levels in postmenopausal women and more research is needed on this condition.

A woman's excessive hair growth and masculine features were due to a rare benign ovarian tumor and endometrial cancer, which improved after surgery.

A woman's male-like physical changes were caused by two rare ovarian conditions.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.